研究|Tibsovo(Ivosidenib)治疗IDH1胆管癌lll期临床试验

Tibsovo(Ivosidenib)艾伏尼布(AG-120) , 是靶向异柠檬酸脱氢酶1(IDH1)突变的口 … 继续阅读研究|Tibsovo(Ivosidenib)治疗IDH1胆管癌lll期临床试验